Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mereo BioPharma (MREO) Exchange Rate Effect (2023 - 2025)

Mereo BioPharma (MREO) has disclosed Exchange Rate Effect for 3 consecutive years, with -$63000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 95.0% to -$63000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Dec 2025, up 895.71% year-over-year, with the annual reading at $1.9 million for FY2025, 895.71% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$63000.0 at Mereo BioPharma, up from -$418000.0 in the prior quarter.
  • The five-year high for Exchange Rate Effect was $1.7 million in Q4 2023, with the low at -$1.3 million in Q4 2024.
  • Average Exchange Rate Effect over 3 years is $369916.7, with a median of $391500.0 recorded in 2023.
  • The sharpest move saw Exchange Rate Effect plummeted 174.91% in 2024, then surged 1433.64% in 2025.
  • Over 3 years, Exchange Rate Effect stood at $1.7 million in 2023, then tumbled by 174.91% to -$1.3 million in 2024, then surged by 95.0% to -$63000.0 in 2025.
  • According to Business Quant data, Exchange Rate Effect over the past three periods came in at -$63000.0, -$418000.0, and $1.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.